Frontier Biotechnologies Inc. (SHA:688221)
China · Delayed Price · Currency is CNY 13.17
-0.45 (-3.30%)
At close: Nov 13, 2026
Frontier Biotechnologies Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -35.81 | -268.05 | -201.38 | -328.96 | -356.76 | -260.06 |
Depreciation & Amortization | 14.36 | 24.04 | 41.74 | 45.36 | 51.28 | 44.04 |
Other Amortization | 29.24 | 19.56 | 0.48 | 1.37 | 1.3 | 1.18 |
Loss (Gain) From Sale of Assets | 0.03 | 0.03 | -0.02 | 3.08 | 0 | -0 |
Asset Writedown & Restructuring Costs | 0 | 0 | 36.7 | 3.22 | 0.01 | - |
Loss (Gain) From Sale of Investments | 1.61 | 1.61 | -84.18 | -16.66 | -19.94 | -38.01 |
Provision & Write-off of Bad Debts | 1.82 | 1.82 | -2.21 | 0.41 | 1.6 | 1.22 |
Other Operating Activities | 78 | 31.96 | 23.38 | 9.2 | 7.27 | -7.19 |
Change in Accounts Receivable | -27.87 | -27.87 | 38.6 | 2.43 | -58.03 | 5.73 |
Change in Inventory | -19.11 | -19.11 | 9.49 | -3.39 | -17.37 | -21.97 |
Change in Accounts Payable | 5.83 | 5.83 | -35.11 | 16.56 | 99.38 | 24.83 |
Change in Other Net Operating Assets | 3.6 | 3.6 | - | 0.22 | 2.24 | 7.16 |
Operating Cash Flow | 51.69 | -226.59 | -172.52 | -267.17 | -289.04 | -243.07 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -11.06 | -29.86 | -18.6 | -129.35 | -140.37 | -327.15 |
Sale of Property, Plant & Equipment | 1.4 | 0.03 | 0.03 | 0.24 | 0 | 0.16 |
Divestitures | 12.34 | 27.47 | 48.66 | - | - | - |
Investment in Securities | 108.29 | 108.29 | -236.49 | 284 | -1 | 271 |
Other Investing Activities | -112.8 | 66.75 | 15.62 | 17.81 | 24.11 | 37.73 |
Investing Cash Flow | -1.83 | 172.68 | -190.78 | 172.7 | -117.27 | -18.26 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Issued | - | 361.85 | 393.93 | 312.8 | 202.57 | 279.69 |
Long-Term Debt Repaid | - | -363.08 | -287.7 | -216.64 | -220.84 | -32 |
Lease Payments | -0.46 | -0.46 | -2.56 | -4.81 | -4.56 | -7.29 |
Net Debt Issued (Repaid) | 2.03 | -1.23 | 106.23 | 96.16 | -18.27 | 247.68 |
Issuance of Common Stock | - | - | - | - | 195.67 | - |
Common Dividends Paid | -5.24 | -8.19 | -14.91 | -14.46 | -15.13 | -5.54 |
Other Financing Activities | -7.05 | -15 | -5.7 | -11.41 | -2.8 | -22.82 |
Financing Cash Flow | -10.25 | -24.42 | 85.61 | 70.29 | 159.46 | 219.32 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | -0.35 | -0.05 | 0 | -0.05 | 0.16 | 0.23 |
Net Cash Flow | 39.26 | -78.38 | -277.68 | -24.23 | -246.68 | -41.78 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 40.63 | -256.45 | -191.12 | -396.52 | -429.42 | -570.22 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | 11.36% | -207.85% | -147.61% | -347.07% | -506.74% | -1407.84% |
Free Cash Flow Per Share | 0.11 | -0.69 | -0.51 | -1.06 | -1.18 | -1.58 |
Levered Free Cash Flow | -17.57 | -51.03 | -371.35 | -343.6 | -403.69 | -482.68 |
Unlevered Free Cash Flow | -16.14 | -45.33 | -364.88 | -338.31 | -400.72 | -481.72 |
Free Cash Flow After Leases | 40.18 | -256.91 | -193.68 | -401.34 | -433.98 | -577.51 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Income Tax Paid | 3.58 | 3.22 | 4.21 | -6.39 | -54.05 | -12.26 |
Change in Working Capital | -37.56 | -37.56 | 12.98 | 15.81 | 26.21 | 15.75 |